Reducing rejection in biomedical devices

A newly developed carbon- and nitrogen-based surface technology can be used in a range of different areas, including disease detection and biofuel production.

The new technology is rich in free radicals – compounds believed to be involved in degenerative disease production when allowed to run free in the body – which are used for good, anchoring proteins to surfaces.

The technology can be used in implantable medical devices such as stents. By coating itself in a patient’s own proteins the surface technology can reduce the chance of rejection and other complications.

Read more at University of Sydney